Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 311

1.

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.

Legro RS, Finegood D, Dunaif A.

J Clin Endocrinol Metab. 1998 Aug;83(8):2694-8.

PMID:
9709933
2.

Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.

Ducluzeau PH, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M, Pugeat M.

J Clin Endocrinol Metab. 2003 Aug;88(8):3626-31.

PMID:
12915646
3.

Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.

Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.

Neuro Endocrinol Lett. 2007 Dec;28(6):807-10.

PMID:
18063948
4.

Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations.

Kauffman RP, Baker VM, Dimarino P, Gimpel T, Castracane VD.

Am J Obstet Gynecol. 2002 Nov;187(5):1362-9.

PMID:
12439532
5.

Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.

Sepilian V, Nagamani M.

J Soc Gynecol Investig. 2005 Feb;12(2):129-34.

PMID:
15695109
6.
7.

Assessment of insulin resistance in lean women with polycystic ovary syndrome.

Morciano A, Romani F, Sagnella F, Scarinci E, Palla C, Moro F, Tropea A, Policola C, Della Casa S, Guido M, Lanzone A, Apa R.

Fertil Steril. 2014 Jul;102(1):250-256.e3. doi: 10.1016/j.fertnstert.2014.04.004. Epub 2014 May 10.

PMID:
24825420
8.

Simplification of continuous infusion of glucose with model assessment in the evaluation of insulin resistance in women with PCOS.

Wang Y, Fedorcsák P, Dale PO, Storeng R, Abyholm T, Tanbo T.

Gynecol Endocrinol. 2001 Jun;15(3):192-7.

PMID:
11447730
9.

Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients.

Ciampelli M, Leoni F, Cucinelli F, Mancuso S, Panunzi S, De Gaetano A, Lanzone A.

J Clin Endocrinol Metab. 2005 Mar;90(3):1398-406. Epub 2004 Dec 14.

PMID:
15598698
10.
11.

[Critical evaluation of the oral glucose tolerance test for the diagnosis of insulin resistance in patients with polycystic ovary syndrome].

Calvar CE, Bengolea SV, Hermes R, Loyato M.

Medicina (B Aires). 2007;67(1):1-7. Spanish.

PMID:
17408014
13.
14.

Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome.

Veltman-Verhulst SM, Goverde AJ, van Haeften TW, Fauser BC.

Hum Reprod. 2013 Aug;28(8):2228-34. doi: 10.1093/humrep/det226. Epub 2013 Jun 5.

PMID:
23739218
15.

Fasting glucose/insulin ratio. An index to differentiate normo from hyperinsulinemic women with polycystic ovary syndrome.

Parra A, Ramírez A, Espinosa de los Monteros A.

Rev Invest Clin. 1994 Sep-Oct;46(5):363-8.

PMID:
7839016
16.

Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome.

Vrbíková J, Bendlová B, Hill M, Vanková M, Vondra K, Stárka L.

Diabetes Care. 2002 Jul;25(7):1217-22.

PMID:
12087022
17.

Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters.

Chapman IM, Wittert GA, Norman RJ.

Clin Endocrinol (Oxf). 1997 Feb;46(2):175-81.

PMID:
9135699
18.

Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.

Ezeh U, Pall M, Mathur R, Azziz R.

Hum Reprod. 2014 Jul;29(7):1508-17. Epub 2014 May 9.

19.

[Insulin release and daily glucose change in polycystic ovary syndrome women with normal glucose tolerance].

Tao MF, Zhu JP, Zhou J, Lu W, Qin W, Teng YC, Jia WP.

Zhonghua Yi Xue Za Zhi. 2009 Mar 17;89(10):659-63. Chinese.

PMID:
19595057
20.

Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.

Yildiz BO, Yarali H, Oguz H, Bayraktar M.

J Clin Endocrinol Metab. 2003 May;88(5):2031-6.

PMID:
12727950

Supplemental Content

Support Center